As COVID-19 vaccine guidance shifts, new data suggest vaccinated patients face no greater clot or death risk than with other respiratory infections.
Opinion|Videos|October 27, 2023
Addressing Vaccine Hesitancy with Patients
Empower your practice with the tools to combat vaccine hesitancy. This informative video tackles the nuanced challenges of addressing vaccine hesitancy, offering healthcare providers valuable strategies to engage with patients and build trust in vaccination. Enhance your communication skills, navigate common concerns, and contribute to the broader mission of achieving widespread immunity against COVID-19 with this video.
Advertisement
Advertisement
Related to this article
New survey data add to the evidence regarding the safe and effective route of administering both COVID-19 and flu vaccines simultaneously.
Researchers provide an update on the adverse events of special interest following patients who received 2024–2025 Pfizer-BioNTech COVID-19 vaccination.
From expert sources and recent data updates to a look at cases amid the ongoing respiratory virus season, this is an updated look at 2026 measles outbreaks in the US.
Phase 2 trial results for the investigational vaccine were presented at IDWeek 2026 in Washington, DC, as the phase 3 program is currently underway.
Researchers assessed the extent of which vaccine fatigue translates to reduced engagement and adherence among patients.
Advertisement
Advertisement
Trending on Drug Topics
1
US Lost Over 3000 Pharmacies From 2022 to 2024, Mostly Chains
2
CVS Plans to Split Off Its Retail Pharmacies, Keeping Specialty Operations
3
How Pharmacist-Led ART Protocol Improves HIV Medication Outcomes
4
Measles Cases Near 5000 in 2026 as Flu Season Starts Earlier Than Usual
5